UniProt ID | PTTG1_HUMAN | |
---|---|---|
UniProt AC | O95997 | |
Protein Name | Securin | |
Gene Name | PTTG1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 202 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Regulatory protein, which plays a central role in chromosome stability, in the p53/TP53 pathway, and DNA repair. Probably acts by blocking the action of key proteins. During the mitosis, it blocks Separase/ESPL1 function, preventing the proteolysis of the cohesin complex and the subsequent segregation of the chromosomes. At the onset of anaphase, it is ubiquitinated, conducting to its destruction and to the liberation of ESPL1. Its function is however not limited to a blocking activity, since it is required to activate ESPL1. Negatively regulates the transcriptional activity and related apoptosis activity of TP53. The negative regulation of TP53 may explain the strong transforming capability of the protein when it is overexpressed. May also play a role in DNA repair via its interaction with Ku, possibly by connecting DNA damage-response pathways with sister chromatid separation.. | |
Protein Sequence | MATLIYVDKENGEPGTRVVAKDGLKLGSGPSIKALDGRSQVSTPRFGKTFDAPPALPKATRKALGTVNRATEKSVKTKGPLKQKQPSFSAKKMTEKTVKAKSSVPASDDAYPEIEKFFPFNPLDFESFDLPEEHQIAHLPLSGVPLMILDEERELEKLFQLGPPSPVKMPSPPWESNLLQSPSSILSTLDVELPPVCCDIDI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATLIYVDK ------CCEEEEEEC | 15.89 | 22814378 | |
3 | Phosphorylation | -----MATLIYVDKE -----CCEEEEEECC | 16.64 | 25106551 | |
6 | Phosphorylation | --MATLIYVDKENGE --CCEEEEEECCCCC | 13.00 | 25106551 | |
9 | Ubiquitination | ATLIYVDKENGEPGT CEEEEEECCCCCCCC | 42.93 | 11179223 | |
16 | Phosphorylation | KENGEPGTRVVAKDG CCCCCCCCEEEECCC | 30.88 | 20068231 | |
21 | Ubiquitination | PGTRVVAKDGLKLGS CCCEEEECCCCCCCC | 40.49 | - | |
21 | Acetylation | PGTRVVAKDGLKLGS CCCEEEECCCCCCCC | 40.49 | 25953088 | |
25 | Ubiquitination | VVAKDGLKLGSGPSI EEECCCCCCCCCCCC | 57.22 | 21906983 | |
25 | Acetylation | VVAKDGLKLGSGPSI EEECCCCCCCCCCCC | 57.22 | 25953088 | |
28 | Phosphorylation | KDGLKLGSGPSIKAL CCCCCCCCCCCCEEC | 58.95 | 25159151 | |
31 | Phosphorylation | LKLGSGPSIKALDGR CCCCCCCCCEECCCC | 40.00 | 25159151 | |
33 | Ubiquitination | LGSGPSIKALDGRSQ CCCCCCCEECCCCCC | 47.43 | 21906983 | |
33 | Acetylation | LGSGPSIKALDGRSQ CCCCCCCEECCCCCC | 47.43 | 25953088 | |
39 | Phosphorylation | IKALDGRSQVSTPRF CEECCCCCCCCCCCC | 40.23 | - | |
42 | Phosphorylation | LDGRSQVSTPRFGKT CCCCCCCCCCCCCCC | 25.67 | - | |
43 | Phosphorylation | DGRSQVSTPRFGKTF CCCCCCCCCCCCCCC | 21.45 | - | |
48 | Ubiquitination | VSTPRFGKTFDAPPA CCCCCCCCCCCCCCC | 43.22 | 20080579 | |
48 | Acetylation | VSTPRFGKTFDAPPA CCCCCCCCCCCCCCC | 43.22 | 26051181 | |
60 | Phosphorylation | PPALPKATRKALGTV CCCCCHHHHHHHHCC | 38.54 | - | |
62 | Ubiquitination | ALPKATRKALGTVNR CCCHHHHHHHHCCCH | 43.54 | - | |
66 | Phosphorylation | ATRKALGTVNRATEK HHHHHHHCCCHHHHH | 18.56 | - | |
87 | Phosphorylation | PLKQKQPSFSAKKMT CCCCCCCCCCCCCCC | 29.37 | 23917254 | |
89 | Phosphorylation | KQKQPSFSAKKMTEK CCCCCCCCCCCCCCC | 43.44 | 21815630 | |
91 | Acetylation | KQPSFSAKKMTEKTV CCCCCCCCCCCCCCH | 41.71 | 25953088 | |
101 | Ubiquitination | TEKTVKAKSSVPASD CCCCHHHHCCCCCCC | 37.23 | 2190698 | |
103 | Phosphorylation | KTVKAKSSVPASDDA CCHHHHCCCCCCCCC | 31.26 | 28555341 | |
107 | Phosphorylation | AKSSVPASDDAYPEI HHCCCCCCCCCCHHH | 29.92 | 28102081 | |
111 | Phosphorylation | VPASDDAYPEIEKFF CCCCCCCCHHHHHHC | 14.37 | 29978859 | |
165 | Phosphorylation | LFQLGPPSPVKMPSP HHCCCCCCCCCCCCC | 45.52 | 19664994 | |
171 | Phosphorylation | PSPVKMPSPPWESNL CCCCCCCCCCCHHHC | 39.84 | 20068231 | |
176 | Phosphorylation | MPSPPWESNLLQSPS CCCCCCHHHCCCCHH | 28.98 | 20068231 | |
181 | Phosphorylation | WESNLLQSPSSILST CHHHCCCCHHHHHHH | 27.07 | 20068231 | |
183 | Phosphorylation | SNLLQSPSSILSTLD HHCCCCHHHHHHHCC | 34.95 | 20068231 | |
184 | Phosphorylation | NLLQSPSSILSTLDV HCCCCHHHHHHHCCC | 30.82 | 20068231 | |
187 | Phosphorylation | QSPSSILSTLDVELP CCHHHHHHHCCCCCC | 25.84 | 20068231 | |
188 | Phosphorylation | SPSSILSTLDVELPP CHHHHHHHCCCCCCC | 24.43 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
31 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
66 | T | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
87 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
89 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
165 | S | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
165 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
183 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
184 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | ANAPC2 | Q9UJX6 | PMID:12956947 |
- | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:18485873 |
- | K | Ubiquitination | E3 ubiquitin ligase | BTRC | Q9Y297 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | CDC20 | Q12834 | PMID:11553328 |
- | K | Ubiquitination | E3 ubiquitin ligase | ANAPC11 | Q9NYG5 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | UBE4B | O95155 | PMID:15611659 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTTG1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. | |
"Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product."; Ramos-Morales F., Dominguez A., Romero F., Luna R., Multon M.-C.,Pintor-Toro J.A., Tortolero M.; Oncogene 19:403-409(2000). Cited for: PHOSPHORYLATION AT SER-165, AND MUTAGENESIS OF SER-165. |